Aquamarine Financial (Cayman) LTD 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Aquamarine Financial (Cayman) LTD disclosed 17 US equity positions worth $1.8bn in its Q2 2026 13F filing. The largest position was BBD at 35.8% of the reported book, followed by YPF and GGAL. Against the Q1 2026 filing, it opened 1 new position, added to 9 and reduced 0 among the top 17 holdings.
What did Aquamarine Financial (Cayman) LTD own in Q2 2026? Top 17 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | BBD BANCO BRADESCO S A | Financial Services | 35.8% | $649.0m | 186,948,134 | 19% | added |
| 2 | YPF YPF SOCIEDAD ANONIMA | Energy | 31.2% | $565.9m | 12,444,948 | 38% | added |
| 3 | GGAL GRUPO FINANCIERO GALICIA S.A | Financial Services | 9.7% | $175.9m | 3,515,564 | 49% | added |
| 4 | NU NU HLDGS LTD | Financial Services | 6.6% | $119.9m | 8,977,636 | 798% | added |
| 5 | BMA BANCO MACRO S A | Financial Services | 4.3% | $78.0m | 842,490 | 58% | added |
| 6 | GGB GERDAU SA | Basic Materials | 3.7% | $67.6m | 16,726,171 | 0% | held |
| 7 | BSBR BANCO SANTANDER BRASIL S A | Financial Services | 3.0% | $54.6m | 10,394,184 | 6% | added |
| 8 | BBAR BANCO BBVA ARGENTINA S A | 1.8% | $33.4m | 1,701,078 | 38% | added | |
| 9 | PAGAYA TECHNOLOGIES LTD | 1.8% | $32.3m | 1,771,209 | – | new | |
| 10 | ORMP ORAMED PHARMACEUTICALS INC | 0.7% | $12.1m | 2,512,175 | 19% | added | |
| 11 | ALPHA TAU MEDICAL LTD | 0.5% | $9.1m | 721,501 | 0% | held | |
| 12 | CSAN COSAN S A | Energy | 0.3% | $6.0m | 2,096,904 | 0% | held |
| 13 | INVZ INNOVIZ TECHNOLOGIES LTD | 0.2% | $4.4m | 5,828,949 | 13% | added | |
| 14 | PULSENMORE LTD | 0.1% | $2.0m | 338,541 | 0% | held | |
| 15 | TGS TRANSPORTADORA DE GAS DEL SU | Energy | 0.0% | $882.9k | 29,696 | 0% | held |
| 16 | CEPU CENTRAL PUERTO S A | 0.0% | $287.0k | 19,314 | 0% | held | |
| 17 | VALENS SEMICONDUCTOR LTD | 0.0% | $15.7k | 559,653 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.